Cargando…
Low-risk DCIS. What is it? Observe or excise?
The issue of overdiagnosis and overtreatment of lesions detected by breast screening mammography has been debated in both international media and the scientific literature. A proportion of cancers detected by breast screening would never have presented symptomatically or caused harm during the patie...
Autores principales: | Pinder, Sarah E., Thompson, Alastair M., Wesserling, Jelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983540/ https://www.ncbi.nlm.nih.gov/pubmed/34448893 http://dx.doi.org/10.1007/s00428-021-03173-8 |
Ejemplares similares
-
Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
por: Byng, Danalyn, et al.
Publicado: (2021) -
Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists
por: Byng, Danalyn, et al.
Publicado: (2021) -
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
por: Alaeikhanehshir, Sena, et al.
Publicado: (2020) -
Should low-risk DCIS lose the cancer label? An evidence review
por: Ma, Tara, et al.
Publicado: (2023) -
Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)